Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Structural Basis of AZD9291 Selectivity for EGFR T790M

Journal Article · · J. Med. Chem.
Research Organization:
Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
Sponsoring Organization:
DOE - Office Of Science; FOREIGN
OSTI ID:
1834870
Journal Information:
J. Med. Chem., Journal Name: J. Med. Chem. Journal Issue: (15) Vol. 63
Country of Publication:
United States
Language:
ENGLISH

References (44)

PRODRG : a tool for high-throughput crystallography of protein–ligand complexes journal July 2004
Accurate and efficient integration for molecular dynamics simulations at constant temperature and pressure journal October 2013
Kinetic Analysis of Epidermal Growth Factor Receptor Somatic Mutant Proteins Shows Increased Sensitivity to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Erlotinib journal August 2006
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study journal December 2019
How Does a Drug Molecule Find Its Target Binding Site? journal June 2011
Binding mode of the breakthrough inhibitor AZD9291 to epidermal growth factor receptor revealed journal December 2015
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib journal February 2005
EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors journal May 2015
EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib journal August 2004
Features and development of Coot journal March 2010
Comparison of multiple Amber force fields and development of improved protein backbone parameters journal November 2006
Osimertinib: First Global Approval journal January 2016
Improved side-chain torsion potentials for the Amber ff99SB protein force field journal January 2010
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor journal June 2006
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer journal April 2015
The u -series: A separable decomposition for electrostatics computation with improved accuracy journal February 2020
Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor Sensitivity journal March 2007
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP journal January 2008
HKL -3000: the integration of data reduction and structure solution – from diffraction images to an initial model in minutes journal July 2006
Phaser crystallographic software journal July 2007
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M journal December 2009
Development and testing of a general amber force field journal January 2004
A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy journal June 2020
Discovery of a Mutant-Selective Covalent Inhibitor of EGFR that Overcomes T790M-Mediated Resistance in NSCLC journal September 2013
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib journal May 2004
Novel D761Y and Common Secondary T790M Mutations in Epidermal Growth Factor Receptor-Mutant Lung Adenocarcinomas with Acquired Resistance to Kinase Inhibitors journal November 2006
Olmutinib: First Global Approval journal June 2016
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination journal September 1998
Discovery of Selective and Noncovalent Diaminopyrimidine-Based Inhibitors of Epidermal Growth Factor Receptor Containing the T790M Resistance Mutation journal November 2014
Rociletinib in EGFR -Mutated Non–Small-Cell Lung Cancer journal April 2015
Transitions to catalytically inactive conformations in EGFR kinase journal April 2013
Optimized Molecular Dynamics Force Fields Applied to the Helix−Coil Transition of Polypeptides journal July 2009
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M journal May 2015
AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer journal June 2014
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain journal February 2005
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy journal June 2004
Constant pressure molecular dynamics algorithms journal September 1994
Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance journal December 2013
Comparison of simple potential functions for simulating liquid water journal July 1983
Canonical dynamics: Equilibrium phase-space distributions journal March 1985
The ORCA program system: The ORCA program system journal June 2011
Oncogenic Mutations Counteract Intrinsic Disorder in the EGFR Kinase and Promote Receptor Dimerization journal May 2012
Psi4 1.1: An Open-Source Electronic Structure Program Emphasizing Automation, Advanced Libraries, and Interoperability journal June 2017

Similar Records

Structural Basis of AZD9291 Selectivity for EGFR T790M
Journal Article · Wed Jul 01 00:00:00 EDT 2020 · J. Med. Chem. · OSTI ID:1838540

Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
Journal Article · Mon Jan 11 23:00:00 EST 2010 · Nature · OSTI ID:1006040

Crystal structure of EGFR T790M/C797S/V948R in complex with EAI045
Journal Article · Sun Jul 15 00:00:00 EDT 2018 · Biochemical and Biophysical Research Communications · OSTI ID:23105732

Related Subjects